Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. [electronic resource]
Producer: 20030930Description: 1310-5 p. digitalISSN:- 1524-4539
- Adult
- Angioplasty, Balloon, Coronary
- Combined Modality Therapy
- Coronary Angiography
- Coronary Artery Disease -- diagnostic imaging
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Female
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Male
- Metalloporphyrins -- administration & dosage
- Middle Aged
- Photochemotherapy -- adverse effects
- Photosensitizing Agents -- administration & dosage
- Stents
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.